https://www.selleckchem.com/pr....oducts/bismuth-subni
4%) as non-LNB patients. Receiver operating characteristic (ROC) curve analysis comparing definite LNB patients with non-LNB patients showed a cut-off value of 85.9 pg/ml for the Quantikine CXCL13 ELISA and 252.2 pg/ml for the recomBead CXCL13 assay. The corresponding sensitivities were 100% (95% confidence interval [CI] 100%-100% (for both), the corresponding specificities were 98.6% [95% CI 96.5%-100%] for the CXCL13 ELISA, and 97.2% [95% CI 93.6%-100%] for the recomBead CXCL13 assay, respectively. This study showed that CX